Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 4-kinase alpha pseudogene 2 (PI4KAP2) is annotated as a **pseudogene** in humans and is located on chromosome 22[6]. It shares sequence similarity with phosphatidylinositol 4-kinase alpha and is predicted based on homology to have kinase-related activity, but evidence suggests it does **not encode a functional protein**[3][4][6]. It is not cataloged as a therapeutic target, does not have established molecular function or involvement in disease, and is not associated with any drugs or mechanisms of action. As a pseudogene, PI4KAP2 does not possess any known biological, pharmacological, or clinical relevance[3][4][6]. Key notes: - The submitted target is a **pseudogene**, so **it is not a functional receptor, enzyme, transporter, or established drug target**[3][4][6]. - Listing as a therapeutic/direct druggable target is incorrect. - If you are searching for the functional kinase, refer to "Phosphatidylinositol 4-kinase alpha" (PI4KA), which is a separate, functional gene/enzyme[1][2][7].
None (does not encode a functional protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 4-kinase alpha pseudogene 2 (PI4KAP2).